CRYSTAL BALL: Open Payments
NPI 1053863688 · DUNGANNON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$250 in 13 payments from 7 companies in 2025. Trend: 2023 $550 · 2024 $414 · 2025 $250
Food & beverage: $250
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 5 | $93 |
| Dexcom, Inc. | 1 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $32 |
| Exact Sciences Corporation | 1 | $24 |
| Lilly USA, LLC | 1 | $14 |
| Novo Nordisk Inc | 1 | $14 |
Products named: FREESTYLE LIBRE 3, Dexcom G6 Transmitter, XIFAXAN, Cologuard Collection Kit, FARXIGA, AIRSUPRA, MOUNJARO, Ozempic.
Industry payments across VA — which companies pay providers there.
